Key result
Additional cardiosurgical procedures along with myectomy were performed in 35.3% of patients with hypertrophic cardiomyopathy, with a hospital mortality rate of ≤1%.
Why the study?
Hypertrophic cardiomyopathy is a progressive genetic myocardial disease increasingly treated with myectomy, but the frequency and reasons for combined cardiac surgeries are not well characterized.
Observational (n=201)
No
Combined cardiac surgeries are required in approximately 35% of patients undergoing myectomy for hypertrophic cardiomyopathy and do not negatively impact immediate or long-term outcomes.
Combined procedures during myectomy appear feasible with low mortality in HCM; observational data extend prior reports but should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sl et al. (2022) conducted an observational in Hypertrophic cardiomyopathy (n=201). Surgical remodeling of the left ventricle (myectomy) was evaluated on Frequency of combined cardiosurgical operations. Additional cardiosurgical procedures along with myectomy were performed in 35.3% of patients with hypertrophic cardiomyopathy, with a hospital mortality rate of ≤1%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: